D-0824-2020 Class II Terminated
FDA drug recall D-0824-2020 was initiated by Pharmaceutical Associates Inc on Jan 14, 2020 and is designated Class II. Reason for recall: Subpotent: Out of specification for assay at the 12-month time point. The recall status is terminated (terminated Jun 3, 2021). Affected quantity: 6288 16 oz bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 5, 2020
- Initiation Date
- Jan 14, 2020
- Termination Date
- Jun 3, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6288 16 oz bottles
Product description
Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai, Pharmaceutical Associates, Inc. Greenville, SC 29605. NDC 0121-0810-16
Reason for recall
Subpotent: Out of specification for assay at the 12-month time point.
Distribution pattern
Distributed Nationwide in the US
Code information
Lots: BB70, BB71 Exp. May 2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0824-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026